Background Whilst the pharmacological profiles and mechanisms of antidepressants are
varied, there are common reasons why they might help people to stop smoking tobacco …

Neurodegeneration and depression are two common co-morbid conditions, particularly
within the aging population. Research has linked neuroinflammation as a major contributing …

Background Smokers with a history of major depression who attempt to stop smoking have a
higher risk of failure than non-depressed smokers. Anecdotal and post-hoc data suggest that …

The aversive aspects of withdrawal from chronic nicotine exposure are thought to be an
important motivational factor contributing to the maintenance of the tobacco habit in human …

Background Individuals with current or past depression are often smokers who are more
nicotine dependent, more likely to suffer from negative mood changes after nicotine …

This article reviews the research on the treatment of cigarette smoking in individuals who
have comorbid mental illnesses or non-nicotinic addictions. The prevalence of smoking in …

Aims: To examine comorbidity between tobacco use, substance-use disorders and mental
health problems among Australian adults aged 18 years and over. Method: Data from the …

Patients with mental illness have a higher incidence of smoking than the general population
and are the major consumers of tobacco products. This population includes subjects with …

The authors conducted a meta-analysis of published studies to (a) evaluate the premise that
a history of major depression is associated with failure to quit smoking and (b) identify …

The advent of bupropion hydrochloride sustained release (Zyban) has heralded a major
change in the options available for smoking cessation pharmacotherapy. Bupropion is a …